MiNK Therapeutics (INKT) Return on Assets [ROA] (2021 - 2026)
MiNK Therapeutics' Return on Assets [ROA] was -116.13% in Q2 2026, up 206.63 percentage points from -322.75% a year earlier but down 14.63 percentage points from the prior quarter.
Powered by 
Analysis
MiNK Therapeutics (INKT) Return on Assets [ROA] (2021 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at MiNK Therapeutics came in at -123.77%, up 90.83 percentage points from FY2024.
- Return on Assets [ROA] shows a four-year change of +13.70 percentage points (FY2021 to FY2025).
- In earlier years, Return on Assets [ROA] was -214.60% in FY2024 (-42.22 pp), -172.38% in FY2023 (-72.08 pp), -100.30% in FY2022 (+37.17 pp) and -137.47% in FY2021.
- Quarterly Return on Assets [ROA] has moved between -381.58% (Q4 2023) and -84.60% (Q4 2025) over five years.
- Compared with a year earlier, Return on Assets [ROA] has increased for four straight quarters, with an average year-over-year change of +95.78 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q4 2024 (a gain of 213.24 percentage points); the worst was Q4 2023 (a drop of 249.12 percentage points).
- Per Business Quant data, INKT's Return on Assets [ROA] in the three quarters before Q2 2026 was -101.49% (Q1 2026), -84.60% (Q4 2025) and -140.08% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | MiNK Therapeutics | 63.96 Mn | 63.96 Mn | - | -116.13% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -116.13% |
| Mar 31, 2026 | -101.49% |
| Dec 31, 2025 | -84.60% |
| Sep 30, 2025 | -140.08% |
| Jun 30, 2025 | -322.75% |
| Mar 31, 2025 | -197.78% |
| Dec 31, 2024 | -168.34% |
| Sep 30, 2024 | -159.21% |
| Jun 30, 2024 | -203.67% |
| Mar 31, 2024 | -364.66% |
| Dec 31, 2023 | -381.58% |
| Sep 30, 2023 | -258.62% |
| Jun 30, 2023 | -195.63% |
| Mar 31, 2023 | -154.64% |
| Dec 31, 2022 | -132.45% |
| Sep 30, 2022 | -107.23% |
| Jun 30, 2022 | -108.53% |
| Mar 31, 2022 | -90.10% |
| Dec 31, 2021 | -138.94% |
API Access
MiNK Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=INKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "INKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=INKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();